DK2152867T3 - Fremgangsmåder til fremstilling af faktor X, aktiveret faktor X, inaktiveret faktor X og inaktiveret faktor Xa - Google Patents

Fremgangsmåder til fremstilling af faktor X, aktiveret faktor X, inaktiveret faktor X og inaktiveret faktor Xa

Info

Publication number
DK2152867T3
DK2152867T3 DK08750714.1T DK08750714T DK2152867T3 DK 2152867 T3 DK2152867 T3 DK 2152867T3 DK 08750714 T DK08750714 T DK 08750714T DK 2152867 T3 DK2152867 T3 DK 2152867T3
Authority
DK
Denmark
Prior art keywords
factor
inactivated
methods
preparing
activated
Prior art date
Application number
DK08750714.1T
Other languages
English (en)
Inventor
Joanne Lloyd
Peter Feldman
Original Assignee
Bio Products Lab Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bio Products Lab Ltd filed Critical Bio Products Lab Ltd
Application granted granted Critical
Publication of DK2152867T3 publication Critical patent/DK2152867T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6432—Coagulation factor Xa (3.4.21.6)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A61K38/4846—Factor VII (3.4.21.21); Factor IX (3.4.21.22); Factor Xa (3.4.21.6); Factor XI (3.4.21.27); Factor XII (3.4.21.38)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21006—Coagulation factor Xa (3.4.21.6)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
DK08750714.1T 2007-05-30 2008-05-29 Fremgangsmåder til fremstilling af faktor X, aktiveret faktor X, inaktiveret faktor X og inaktiveret faktor Xa DK2152867T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0710321.1A GB0710321D0 (en) 2007-05-30 2007-05-30 Method
PCT/GB2008/001810 WO2008145989A1 (en) 2007-05-30 2008-05-29 Methods for preparing factor x, activated factor x, inactivated factor x and inactivated factor xa, and pharmaceutical compositions comprising same

Publications (1)

Publication Number Publication Date
DK2152867T3 true DK2152867T3 (da) 2013-01-14

Family

ID=38289546

Family Applications (1)

Application Number Title Priority Date Filing Date
DK08750714.1T DK2152867T3 (da) 2007-05-30 2008-05-29 Fremgangsmåder til fremstilling af faktor X, aktiveret faktor X, inaktiveret faktor X og inaktiveret faktor Xa

Country Status (12)

Country Link
US (1) US8906366B2 (da)
EP (1) EP2152867B1 (da)
JP (1) JP5261478B2 (da)
CA (1) CA2687604C (da)
DK (1) DK2152867T3 (da)
ES (1) ES2400014T3 (da)
GB (1) GB0710321D0 (da)
IL (1) IL201931A (da)
PL (1) PL2152867T3 (da)
PT (1) PT2152867E (da)
SI (1) SI2152867T1 (da)
WO (1) WO2008145989A1 (da)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2012001660A (es) * 2009-08-06 2012-03-26 Ironwood Pharmaceuticals Inc Formulaciones que contienen linaclotida para adminstracion oral.
AU2011343813B2 (en) * 2010-12-15 2015-05-21 Takeda Pharmaceutical Company Limited Eluate collection using conductivity gradient
EP2934603A1 (en) * 2012-12-20 2015-10-28 Omrix Biopharmaceuticals Ltd. Viral inactivated biological mixture
FR3000895B1 (fr) * 2013-01-11 2017-02-24 Laboratoire Francais Du Fractionnement Et Des Biotechnologies Sa Utilisation d'antidotes d'inhibiteurs de la coagulation indiques dans la prevention ou le traitement de pathologies thromboemboliques
AR102331A1 (es) 2014-08-12 2017-02-22 Baxalta Inc Activación del factor x
FR3032621A1 (fr) 2015-02-13 2016-08-19 Lab Francais Du Fractionnement Colle biologique et son utilisation comme medicament
EP3590528A1 (en) 2018-07-06 2020-01-08 Octapharma AG Fx activation process and its use in the preparation of a fxa composition

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4481189A (en) 1982-04-14 1984-11-06 New York Blood Center Inc. Process for preparing sterilized plasma and plasma derivatives
US4540573A (en) 1983-07-14 1985-09-10 New York Blood Center, Inc. Undenatured virus-free biologically active protein derivatives
US4613501A (en) 1984-12-21 1986-09-23 New York Blood Center, Inc. Inactivation of viruses in labile blood derivatives
GB8729822D0 (en) * 1987-12-22 1988-02-03 Central Blood Lab Authority Chemical process
US5120537A (en) * 1989-06-14 1992-06-09 Oklahoma Medical Research Foundation Factor xa based anticoagulant compositions
IT1262899B (it) * 1992-03-27 1996-07-22 Sclavo Spa Processo per l'isolamento di fattore ix, fattore x e fattore ii altamente purificati dal complesso protrombinico o dal plasma umano
US5219995A (en) * 1992-07-14 1993-06-15 Alpha Therapeutic Corporation Plasma fraction purification
US5589571A (en) * 1994-10-28 1996-12-31 Cor Therapeutics, Inc. Process for production of inhibited forms of activated blood factors
AT405516B (de) * 1997-02-27 1999-09-27 Immuno Ag Faktor x-analoge mit modifizierter proteasespaltstelle
WO2001051067A1 (en) * 2000-01-13 2001-07-19 Baxter International Inc. Multiple inactivated blood factor anticoagulant composition
DE60322513D1 (de) * 2002-02-27 2008-09-11 Immunex Corp Stabilisierte TNFR-Fc Formulierung mit Arginin
SE0203551D0 (sv) * 2002-12-02 2002-12-02 Biovitrum Ab Prothrombin purification
KR20130128013A (ko) 2004-12-23 2013-11-25 노보 노르디스크 헬스 케어 악티엔게젤샤프트 관심있는 비타민 ｋ-의존성 단백질을 포함한 조성물 중의 단백질 오염물질의 양의 감소

Also Published As

Publication number Publication date
US8906366B2 (en) 2014-12-09
AU2008257222B2 (en) 2013-05-16
AU2008257222A1 (en) 2008-12-04
IL201931A (en) 2013-04-30
EP2152867B1 (en) 2012-11-28
JP2010528096A (ja) 2010-08-19
CA2687604C (en) 2016-04-12
WO2008145989A1 (en) 2008-12-04
SI2152867T1 (sl) 2013-03-29
ES2400014T3 (es) 2013-04-05
PT2152867E (pt) 2012-12-17
GB0710321D0 (en) 2007-07-11
IL201931A0 (en) 2011-08-01
US20100233149A1 (en) 2010-09-16
JP5261478B2 (ja) 2013-08-14
PL2152867T3 (pl) 2013-04-30
CA2687604A1 (en) 2008-12-04
EP2152867A1 (en) 2010-02-17

Similar Documents

Publication Publication Date Title
DK2270818T3 (da) Polyelektrolyt og fremgangsmåde til fremstilling af polyelektrolytten
DK2451643T3 (da) Foliefrit emballagelaminat, fremgansgmåde til fremstilling af emballagelaminat og emballagebeholder deraf
DK2687596T3 (da) Faktor VII-polypeptider som er modificerede og anvendelser deraf
BRPI0814466A2 (pt) Método.
DK2404667T3 (da) Hydrocracking-katalysator, fremgangsmåde til fremstilling af samme og anvendelse deraf
DK2346552T4 (da) Lægemiddelafgivelsesanordning og fremgangsmåde til fremstilling af en lægemiddelafgivelsesanordning
ATE513831T1 (de) Pyridinä3,4-büpyrazinone
DK2467173T3 (da) Sårbandager, fremgangsmåder til anvendelse heraf og fremgangsmåder til dannelse deraf
DK2376015T3 (da) Pneumopedisk-ortodontisk instrument, system og fremgangsmåde.
DK2225185T3 (da) Lyd-absorberende, bestandige paneler og fremgangsmåde til fremstilling deraf
IL184701A0 (en) Atm activated by cell-phone
DK2182863T3 (da) Åbningsdilatator
DK2200646T3 (da) RNA-Vacciner
FR2904323B1 (fr) Luminophores coeur-coquille.
BRPI0809573A2 (pt) composição, e, método
DK1852430T3 (da) Fremgangsmåde til fremstilling af proanthocyanidinoligomer
BRPI0909770A2 (pt) Vacina, e, kit
BRPI0812803A2 (pt) Dessalinização
DK2134663T3 (da) Beskyttelseslag på højtemperaturudholdende chromoxiddannende substrater, og fremgangsmåde til fremstilling deraf
DE602008003049D1 (de) Locher
BRPI0814167A2 (pt) Composição, e, método
DK2152867T3 (da) Fremgangsmåder til fremstilling af faktor X, aktiveret faktor X, inaktiveret faktor X og inaktiveret faktor Xa
BRPI0809678A2 (pt) Métodos
DK2090318T3 (da) Profylaktisk tuberkulosevaccine
DK2203410T3 (da) Fremgangsmåde til fremstilling af 4-aminobut-2-enolider